- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 495/14 - Ortho-condensed systems
Patent holdings for IPC class C07D 495/14
Total number of patents in this class: 1174
10-year publication summary
|
71
|
63
|
89
|
88
|
89
|
80
|
76
|
81
|
79
|
80
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Dana-Farber Cancer Institute, Inc. | 2600 |
51 |
| Merck Patent GmbH | 5773 |
47 |
| FUJIFILM Corporation | 29702 |
39 |
| Bristol-myers Squibb Company | 4850 |
23 |
| Sumitomo Chemical Company, Limited | 9086 |
23 |
| Vanderbilt University | 1918 |
23 |
| Duk San Neolux Co., Ltd. | 661 |
20 |
| Genentech, Inc. | 4012 |
15 |
| Incyte Holdings Corporation | 668 |
15 |
| F. Hoffmann-La Roche AG | 7947 |
13 |
| The Regents of the University of Michigan | 4753 |
13 |
| Samsung Electronics Co., Ltd. | 147983 |
12 |
| Hoffmann-La Roche Inc. | 3484 |
12 |
| Boehringer Ingelheim International GmbH | 4648 |
12 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2882 |
12 |
| C4 Theraprutics, Inc. | 59 |
12 |
| LG Chem, Ltd. | 17680 |
11 |
| Idemitsu Kosan Co., Ltd. | 4239 |
11 |
| The University of Tokyo | 4224 |
11 |
| Novartis AG | 10709 |
10 |
| Other owners | 789 |